Search

Your search keyword '"Ceccherini Silberstein, F"' showing total 755 results

Search Constraints

Start Over You searched for: Author "Ceccherini Silberstein, F" Remove constraint Author: "Ceccherini Silberstein, F"
755 results on '"Ceccherini Silberstein, F"'

Search Results

201. Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients:an observational study using pooled European cohort data

202. Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy

203. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study

204. Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

205. Key genetic signatures in the whole pre-S1/Pre-S2/s gene correlate eith HBV-induced carcinogenesis by affecting HBsAG secretion and release

206. TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

208. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

209. Performance of genotypic tropism testing on proviral DNAin clinical practice: results from the DIVA Study Group

210. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

212. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

213. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

214. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

215. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

222. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

223. P0903 : Slow HCV kinetics following sofosbuvir + ribavirin administration in real-life setting of liver transplant recipients with severe recurrent hepatitis C

224. P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing

225. P0912 : Early-phase HCV kinetics and role of pre-existing resistance in cirrhotic or interferon-insensitive patients on daclatasvir plus asunaprevir

226. P0614 : Key HBsAg mutations significantly correlate with HCC, hamper HBsAg secretion and promote cell proliferation in vitro

227. Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors

228. Slow achievement of HCV-RNA undetectability in cirrhotic patients treated with sofosbuvir+ribavirin: possible clinical implications in the liver transplant list management

229. Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029

230. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study

231. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

232. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

233. Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

234. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

235. Improved weighted darunavir genotypic mutation score predicting treatment response for HIV-1 subtype B and non-B infected patients receiving darunavir in a salvage regimen

236. KEY GENETIC MARKERS IN THE FULL-LENGTH HBSAG GENE CORRELATE WITH HBV-DRIVEN CARCINOGENESIS BY AFFECTING HBSAG SECRETION AND RELEASE

237. Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

238. Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

239. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

240. Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy

241. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

242. Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

243. Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

244. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis

246. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

247. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina

248. Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria

249. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

Catalog

Books, media, physical & digital resources